PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM)
CUSIP: 70387R403
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,367,621
- Total 13F shares
- 1,917,493
- Share change
- +382,415
- Total reported value
- $426,481
- Price per share
- $0.22
- Number of holders
- 27
- Value change
- +$27,422
- Number of buys
- 11
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUMMIT WEALTH GROUP LLC / CO |
13F
|
Company |
0.68%
|
43,017
|
$2,291,516 | — | 30 Sep 2025 | |
| Ayrton Capital LLC |
13D/G
|
— |
9.9%
|
1,226,316
|
$858,421 | $0 | 31 Dec 2024 | |
| Sargent Investment Group, LLC |
13D/G
|
— |
5.8%
|
1,006,300
|
$604,183 | $0 | 01 Jul 2025 | |
| FIRST MANHATTAN CO. LLC. |
13D/G
13F
|
Company |
4.3%
|
714,100
|
$499,870 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
208,371
|
$90,225 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
2.4%
|
152,304
|
$65,643 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
96,574
|
$41,823 | — | 30 Sep 2025 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
72,660
|
$31,316 | — | 30 Sep 2025 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
1%
|
65,047
|
$28,035 | — | 30 Sep 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.87%
|
55,533
|
$23,935 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
46,489
|
$20,037 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.61%
|
38,974
|
$17,000 | — | 30 Sep 2025 | |
| Obermeyer Wealth Partners |
13F
|
Company |
0.34%
|
21,500
|
$9,267 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
20,854
|
$9,030 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.19%
|
12,303
|
$5,327 | — | 30 Sep 2025 | |
| XML Financial, LLC |
13F
|
Company |
0.16%
|
10,067
|
$4,339 | — | 30 Sep 2025 | |
| CWM, LLC |
13F
|
Company |
0.1%
|
6,412
|
$3,000 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
5,026
|
$2,166 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
4,386
|
$1,890 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
1,644
|
$709 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
869
|
$375 | — | 30 Sep 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
836
|
$360 | — | 30 Sep 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
295
|
$128 | — | 30 Sep 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
246
|
$104 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
131
|
$56 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
109
|
$47 | — | 30 Sep 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
95
|
$41 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
81
|
$35 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
69
|
$29 | — | 30 Sep 2025 | |
| Binnacle Investments Inc |
13F
|
Company |
0%
|
67
|
$29 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
38
|
$16 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
30
|
$13 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
18
|
$8 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
12
|
$5 | — | 30 Sep 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
5
|
$2 | — | 30 Sep 2025 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) as of Q4 2025
As of 31 Dec 2025,
PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,917,493 shares.
The largest 10 holders included
FIRST MANHATTAN CO. LLC., VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GSA CAPITAL PARTNERS LLP, LPL Financial LLC, and XTX Topco Ltd.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
32
Q4 2025 holders
27
Holder diff
-5
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.